Healthcare provider profile · identity verified

Zbigniew Cichon, M.D.

Internal Medicine · NORTH WILKESBORO, NC · NPI 1881696243

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	417	92
Levothyroxine Sodium	Levothyroxine Sodium	391	79
Omeprazole	Omeprazole	365	80
Metformin Hcl Er	Metformin Hcl	332	77
Potassium Chloride	Potassium Chloride	312	56
Amlodipine Besylate	Amlodipine Besylate	297	65
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	274	75
Gabapentin	Gabapentin	263	56
Simvastatin	Simvastatin	236	53
Metoprolol Succinate	Metoprolol Succinate	234	55
Montelukast Sodium	Montelukast Sodium	226	51
Tamsulosin Hcl	Tamsulosin Hcl	174	42
Meloxicam	Meloxicam	165	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	155	30
Azithromycin	Azithromycin	151	106
Pantoprazole Sodium	Pantoprazole Sodium	150	42
Prednisone	Prednisone	150	91
Lisinopril	Lisinopril	145	36
Zolpidem Tartrate	Zolpidem Tartrate	128	21
Trazodone Hcl	Trazodone Hcl	127	28
Furosemide	Furosemide	126	32
Hydrochlorothiazide	Hydrochlorothiazide	126	31
Sertraline Hcl	Sertraline Hcl	121	26
Eliquis	Apixaban	120	17
Escitalopram Oxalate	Escitalopram Oxalate	117	26
Clopidogrel	Clopidogrel Bisulfate	116	24
Rosuvastatin Calcium	Rosuvastatin Calcium	116	24
Spironolactone	Spironolactone	105	23
Glimepiride	Glimepiride	103	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	94	63
Labetalol Hcl	Labetalol Hcl	94	25
Doxycycline Hyclate	Doxycycline Hyclate	93	75
Warfarin Sodium	Warfarin Sodium	79	14
Allopurinol	Allopurinol	77	21
Metoprolol Tartrate	Metoprolol Tartrate	77	21
Methotrexate	Methotrexate Sodium	74	13
Donepezil Hcl	Donepezil Hcl	69	14
Metformin Hcl	Metformin Hcl	68	14
Alprazolam	Alprazolam	66	38
Atenolol	Atenolol	66	14
Citalopram Hbr	Citalopram Hydrobromide	65	suppressed
Finasteride	Finasteride	64	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	61	13
Fenofibrate	Fenofibrate	61	11
Valsartan	Valsartan	60	15
Verapamil Er	Verapamil Hcl	60	11
Carvedilol	Carvedilol	57	11
Oxybutynin Chloride Er	Oxybutynin Chloride	57	14
Ezetimibe	Ezetimibe	52	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	50	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	47	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	20
Diltiazem Hcl	Diltiazem Hcl	38	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	37	suppressed
Losartan Potassium	Losartan Potassium	37	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	36	suppressed
Arnuity Ellipta	Fluticasone Furoate	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	15
Cephalexin	Cephalexin	33	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Ondansetron Odt	Ondansetron	32	27
Olanzapine	Olanzapine	31	suppressed
Primidone	Primidone	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Terbinafine Hcl	Terbinafine Hcl	28	12
Estradiol	Estradiol	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	22
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Fluconazole	Fluconazole	25	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	16
Nitroglycerin	Nitroglycerin	22	13
Famotidine	Famotidine	21	suppressed
Ozempic	Semaglutide	21	suppressed
Promethazine Hcl	Promethazine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	15
Enalapril Maleate	Enalapril Maleate	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Digoxin	Digoxin	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Metronidazole	Metronidazole	18	16
Cefuroxime	Cefuroxime Axetil	17	13
Meclizine Hcl	Meclizine Hcl	17	suppressed
Nystatin	Nystatin	17	17
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	15
Clonazepam	Clonazepam	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	11
Entresto	Sacubitril/Valsartan	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Baclofen	Baclofen	13	suppressed
Invokana	Canagliflozin	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Temazepam	Temazepam	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed
Xanax	Alprazolam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error